Assistant Professor of Ophthalmology
Director, Global Ophthalmology, Emory (GO-Emory)
Danny Haddad, MD serves as director of the Emory Eye Center’s Global Vision Initiative effective September 1, 2013.
Haddad is former director of the Atlanta-based International Trachoma Initiative (ITI) from 2009 to 2013. A partnership between Pfizer and The Task Force for Global Health, ITI coordinates the annual billion-dollar Zithromax donation program in support of the global effort to eliminate blinding trachoma by 2020.
Haddad was part of a seminal conversation about Emory’s Global Vision Initiative in 2009 with Eye Center director Timothy Olsen, MD, and then-Global Vision Initiative’s co-lead architect Paul Courtright, DrPH, of the Kilimanjaro Center for Community Ophthalmology (KCCO) in Tanzania. The three decided that forging partnerships with Atlanta organizations such as ITI, The Carter Center and the CDC, for example, were crucial. Additionally, the necessity of a strong, full-time leader for the initiative was suggested. Courtight and Global Vision Initiative co-lead architect Susan Lewallen, MD, also of KCCO, have provided leadership for the program since its inception in 2011.
Haddad was born in Hoogezand, the Netherlands, and received his medical degree from the State University of Groningen, the Netherlands. After his graduation, he was a Helen Keller International (HKI) volunteer working as manager of the Irian Jaya Eye Care Project in Indonesia. Haddad continued working with HKI in several different capacities, including as Africa regional coordinator for Onchocerciasis and Trachoma, based in Niger, director for Onchocerciasis, country director for Tanzania and technical advisor for eye care, based in Senegal.
During his study he was active in training staff of eye hospitals in Africa and Asia to repair their surgical instruments and produce medical supplies using appropriate technology.
Between positions at HKI, Haddad worked as a resident in medical microbiology at the Academic Medical Center (AMC) of the University of Amsterdam in the Netherlands, where he focused on diagnosis and treatment of parasitic diseases. He has more than 18 years of experience in blindness prevention in developing countries, with specific interests in elimination of blinding trachoma and controlling river blindness.
Before joining ITI, Haddad served as the director of the Children Without Worms program, a partnership between Johnson & Johnson and The Task Force that supports global efforts to reduce the burden of soil-transmitted helminth (STH) infections in children.
Haddad holds memberships in the American Society of Tropical Medicine and Hygiene; the International Society of Geographical and Epidemiological Ophthalmology; and the Royal Society of Tropical Medicine and Hygiene.
Haddad is a member of the board of the International Agency for the Prevention of Blindness (IABP). He serves on the Advisory Committee of the Global Trachoma Mapping Project, the Technical Advisory Committee of Helen Keller International and on the Technical Advisory Board of the END Fund and has served on the Technical Consultative Committee of the WHO’s Africa Programme for Onchocerciasis Control and is a former chairperson of the Non-Governmental Development Organization Coordination Group for Onchocerciasis control.
He also holds memberships in the American Society of Tropical Medicine and Hygiene, International Society of Geographical and Epidemiological Ophthalmology, and Royal Society of Tropical Medicine and Hygiene.
State University Of Groningen, The Netherlands, 1990-96
State University of Groningen, The Netherlands, 1996-98
Residency in Medical Microbiology. Academic Medical Center, University of Amsterdam, The Netherlands, 2004-06
Copyright © Emory Eye Center - All Rights Reserved | The Emory Clinic Building B, 1365B Clifton Road, NE, Atlanta, Georgia 30322 USA